Accord Healthcare is voluntarily recalling 1 lot of Daptomycin for Injection 500mg/vial, and Daptomycin for Injection 350mg/vial to the consumer level due to a product mix-up. According to a product ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has introduced Daptomycin for Injection in the United States. Daptomycin for Injection, an antibiotic, is a generic alternative to ...

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has received FDA approval for Daptomycin for Injection and the product is available immediately for customers in the United States ...

December 13, 2010 — The US Food and Drug Administration (FDA) has approved a new delivery method for once-daily daptomycin injection (Cubicin; Cubist Pharmaceuticals, Inc), allowing its administration ...

Accord Healthcare, Inc. is voluntarily recalling a single lot of Daptomycin for Injection 500 mg/vial, and Daptomycin for Injection 350 mg/vial product contained in cartons imprinted with lot # ...

Mylan issues a recall on 500mg/vial daptomycin for injection after finding particulates in a single-dose vial. (Fierce Pharma) () On the heels of a carcinogen scare that drove the company to pull ...

One lot of an injection medicine for serious skin infections and staph bloodstream infections has been recalled for “visible particulates.” After Mylan found that in a dose of Daptomycin for Injection ...

Feb. 6, 2006 — The European Commission has approved daptomycin intravenous infusion for the treatment of complicated skin and soft-tissue infections caused by gram-positive bacteria; Heath Canada has ...

Dr Reddy’s Laboratories Ltd. today announced the launch of Daptomycin for Injection, 500mg/vial single-dose vial, a therapeutic equivalent generic version of Cubicin for Injection, approved by the US ...

According to Mylan, the administration of the recalled product may lead to “serious adverse events including, but not limited to, local irritation, vasculitis/phlebitis, antigenic or allergic ...